Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.

[1]  J. Alfredsson,et al.  Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report. , 2020, JACC. Cardiovascular interventions.

[2]  M. Patterson,et al.  Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial. , 2019, JACC. Cardiovascular interventions.

[3]  P. Porela,et al.  Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial , 2019, The Lancet.

[4]  Zhilu Wang,et al.  Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease , 2019, Medicine.

[5]  M. Shishehbor,et al.  Outcomes with drug‐coated balloons in small‐vessel coronary artery disease , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  J. Kärkkäinen,et al.  Percutaneous coronary intervention with drug‐coated balloon‐only strategy in stable coronary artery disease and in acute coronary syndromes: An all‐comers registry study , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  N. Frey,et al.  Prospective, large‐scale multicenter trial for the use of drug‐coated balloons in coronary lesions: The DCB‐only All‐Comers Registry , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[9]  P. Stella,et al.  Coronary artery treatment with an urea-based paclitaxel-coated balloon: The European wide Falcon all comers DCB Registry (FALCON-Registry). , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  U. Berglund,et al.  Long‐term efficacy of drug coated balloons compared with new generation drug‐eluting stents for the treatment of de novo coronary artery lesions , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[11]  S. Winkler,et al.  Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial , 2018, The Lancet.

[12]  U. Christians,et al.  Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons , 2018, Cardiovascular engineering and technology.

[13]  B. Levkau,et al.  SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry. , 2017, International journal of cardiology.

[14]  L. Räber,et al.  Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries: A Network Meta-Analysis. , 2016, JACC. Cardiovascular interventions.

[15]  A. Gutiérrez-Barrios,et al.  Comparison of two different drug-coated balloons for the treatment of in-stent restenosis: A long-term single-centre experience. , 2016, Cardiovascular revascularization medicine : including molecular interventions.

[16]  J. Fajadet,et al.  DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  P. Stella,et al.  Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis , 2015, Clinical Research in Cardiology.

[18]  B. Merkely,et al.  Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  R. Torguson,et al.  Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  A. Colombo,et al.  A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. , 2012, Journal of the American College of Cardiology.

[21]  P. Barragan,et al.  SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. , 2012, Journal of the American College of Cardiology.

[22]  J. Harnek,et al.  Comparison of two drug-eluting balloons: a report from the SCAAR registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  M. Joner,et al.  Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  L. Wallentin,et al.  Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .

[25]  H. Ackermann,et al.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter , 2010, Clinical Research in Cardiology.

[26]  A. Baumbach,et al.  Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. , 2000, Journal of the American College of Cardiology.